Ola Landgren
Dr. Ola Landgren is a renowned figure in the field of medicine with a background in M.D., Ph.D. studies at prestigious institutions like Karolinska Institute and Lund University in Sweden.
Throughout his career, Dr. Landgren has held key leadership positions at various renowned organizations, such as being the Leader of the Experimental Therapeutics Program at Sylvester Comprehensive Cancer Center.
His expertise extends to academia where he has been a Professor of Medicine and Chief of the Myeloma Program at the University of Miami and Weill Cornell Medicine.
Prior to these roles, he also served as the Chief of the Myeloma Service at Memorial Sloan Kettering Cancer Center and held significant positions at the National Cancer Institute as a Senior Investigator and Chief of the Multiple Myeloma Section.
Dr. Landgren has made significant contributions to the field of medicine, especially in the areas of cancer research and therapeutics.